HIGHLIGHTS
- who: Bruno Brochet and colleagues from the Neurologie, CHU de Nice, Nice, France Editor: Tim Friede, University Medical Center have published the paper: Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0168834]. January 3, 2017 of /1371/
- what: The aims of the present randomized controlled trial were to assess the efficacy of CPM in delaying disability progression, and the safety of IV pulses of CPM administered over two years, relative to IV pulses of methylprednisolone (MP). The aim of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.